The market is mainly driven by the significant applications of Recombinant DNA Technology in various end use industries. The expanding demands from the Biotechnology and Pharmaceutical Companies, Academic & Government Research Institutes and Others,, are propelling Recombinant DNA Technology market. Therapeutic Agent, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Vaccine segment is estimated at % CAGR for the next seven-year period.

Asia Pacific shows high growth potential for Recombinant DNA Technology market, driven by demand from China, the second largest economy with some signs of stabilising, the Recombinant DNA Technology market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Recombinant DNA Technology, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Recombinant DNA Technology market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Recombinant DNA Technology market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Recombinant DNA Technology sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Recombinant DNA Technology covered in this report include Monsanto Company, Roche, Biogen, Amgen, Novartis, Eli Lilly and Company, GenScript, Pfizer Inc. and Novo Nordisk, etc.

The global Recombinant DNA Technology market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Monsanto Company

Roche

Biogen

Amgen

Novartis

Eli Lilly and Company

GenScript

Pfizer Inc.

Novo Nordisk

Sanofi

Merck KGaA

Profacgen

Biocon

GlaxoSmithKline

Cibus

Horizon Discovery Group

New England Biolabs

Scope of Recombinant DNA Technology - Market Report

Report Metric	Details
Report Name	Recombinant DNA Technology - Market
Forecasted market size in 2029	US$ 5388.6 million
CAGR	8.6%
Forecasted years	2023 - 2029
Global Recombinant DNA Technology market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Recombinant DNA Technology market, Segment by Type:	Therapeutic Agent Vaccine Biotech Crops Specialty Chemicals
Global Recombinant DNA Technology market, by Application	Biotechnology and Pharmaceutical Companies Academic & Government Research Institutes Others
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Recombinant DNA Technology companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What is the Recombinant DNA Technology - Market size in 2029?

Ans: The Recombinant DNA Technology - Market size in 2029 will be US$ 5388.6 million.

What are the Application segmentation covered in the Recombinant DNA Technology - Market report?

Ans: The Applications covered in the Recombinant DNA Technology - Market report are Biotechnology and Pharmaceutical Companies, Academic & Government Research Institutes, Others

What are the Type segmentation covered in the Recombinant DNA Technology - Market report?

Ans: The Types covered in the Recombinant DNA Technology - Market report are Therapeutic Agent, Vaccine, Biotech Crops, Specialty Chemicals

1 Market Overview of Recombinant DNA Technology

1.1 Recombinant DNA Technology Market Overview

1.1.1 Recombinant DNA Technology Product Scope

1.1.2 Recombinant DNA Technology Market Status and Outlook

1.2 Global Recombinant DNA Technology Market Size Overview by Region 2018 VS 2022 VS 2029

1.3 Global Recombinant DNA Technology Market Size by Region (2018-2029)

1.4 Global Recombinant DNA Technology Historic Market Size by Region (2018-2023)

1.5 Global Recombinant DNA Technology Market Size Forecast by Region (2024-2029)

1.6 Key Regions, Recombinant DNA Technology Market Size (2018-2029)

1.6.1 North America Recombinant DNA Technology Market Size (2018-2029)

1.6.2 Europe Recombinant DNA Technology Market Size (2018-2029)

1.6.3 Asia-Pacific Recombinant DNA Technology Market Size (2018-2029)

1.6.4 Latin America Recombinant DNA Technology Market Size (2018-2029)

1.6.5 Middle East & Africa Recombinant DNA Technology Market Size (2018-2029)

2 Recombinant DNA Technology Market by Type

2.1 Introduction

2.1.1 Therapeutic Agent

2.1.2 Vaccine

2.1.3 Biotech Crops

2.1.4 Specialty Chemicals

2.2 Global Recombinant DNA Technology Market Size by Type: 2018 VS 2022 VS 2029

2.2.1 Global Recombinant DNA Technology Historic Market Size by Type (2018-2023)

2.2.2 Global Recombinant DNA Technology Forecasted Market Size by Type (2024-2029)

2.3 Key Regions Market Size by Type

2.3.1 North America Recombinant DNA Technology Revenue Breakdown by Type (2018-2029)

2.3.2 Europe Recombinant DNA Technology Revenue Breakdown by Type (2018-2029)

2.3.3 Asia-Pacific Recombinant DNA Technology Revenue Breakdown by Type (2018-2029)

2.3.4 Latin America Recombinant DNA Technology Revenue Breakdown by Type (2018-2029)

2.3.5 Middle East and Africa Recombinant DNA Technology Revenue Breakdown by Type (2018-2029)

3 Recombinant DNA Technology Market Overview by Application

3.1 Introduction

3.1.1 Biotechnology and Pharmaceutical Companies

3.1.2 Academic & Government Research Institutes

3.1.3 Others

3.2 Global Recombinant DNA Technology Market Size by Application: 2018 VS 2022 VS 2029

3.2.1 Global Recombinant DNA Technology Historic Market Size by Application (2018-2023)

3.2.2 Global Recombinant DNA Technology Forecasted Market Size by Application (2024-2029)

3.3 Key Regions Market Size by Application

3.3.1 North America Recombinant DNA Technology Revenue Breakdown by Application (2018-2029)

3.3.2 Europe Recombinant DNA Technology Revenue Breakdown by Application (2018-2029)

3.3.3 Asia-Pacific Recombinant DNA Technology Revenue Breakdown by Application (2018-2029)

3.3.4 Latin America Recombinant DNA Technology Revenue Breakdown by Application (2018-2029)

3.3.5 Middle East and Africa Recombinant DNA Technology Revenue Breakdown by Application (2018-2029)

4 Recombinant DNA Technology Competition Analysis by Players

4.1 Global Recombinant DNA Technology Market Size by Players (2018-2023)

4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Recombinant DNA Technology as of 2022)

4.3 Date of Key Players Enter into Recombinant DNA Technology Market

4.4 Global Top Players Recombinant DNA Technology Headquarters and Area Served

4.5 Key Players Recombinant DNA Technology Product Solution and Service

4.6 Competitive Status

4.6.1 Recombinant DNA Technology Market Concentration Rate

4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles

5.1 Monsanto Company

5.1.1 Monsanto Company Profile

5.1.2 Monsanto Company Main Business

5.1.3 Monsanto Company Recombinant DNA Technology Products, Services and Solutions

5.1.4 Monsanto Company Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)

5.1.5 Monsanto Company Recent Developments

5.2 Roche

5.2.1 Roche Profile

5.2.2 Roche Main Business

5.2.3 Roche Recombinant DNA Technology Products, Services and Solutions

5.2.4 Roche Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)

5.2.5 Roche Recent Developments

5.3 Biogen

5.3.1 Biogen Profile

5.3.2 Biogen Main Business

5.3.3 Biogen Recombinant DNA Technology Products, Services and Solutions

5.3.4 Biogen Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)

5.3.5 Amgen Recent Developments

5.4 Amgen

5.4.1 Amgen Profile

5.4.2 Amgen Main Business

5.4.3 Amgen Recombinant DNA Technology Products, Services and Solutions

5.4.4 Amgen Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)

5.4.5 Amgen Recent Developments

5.5 Novartis

5.5.1 Novartis Profile

5.5.2 Novartis Main Business

5.5.3 Novartis Recombinant DNA Technology Products, Services and Solutions

5.5.4 Novartis Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)

5.5.5 Novartis Recent Developments

5.6 Eli Lilly and Company

5.6.1 Eli Lilly and Company Profile

5.6.2 Eli Lilly and Company Main Business

5.6.3 Eli Lilly and Company Recombinant DNA Technology Products, Services and Solutions

5.6.4 Eli Lilly and Company Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)

5.6.5 Eli Lilly and Company Recent Developments

5.7 GenScript

5.7.1 GenScript Profile

5.7.2 GenScript Main Business

5.7.3 GenScript Recombinant DNA Technology Products, Services and Solutions

5.7.4 GenScript Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)

5.7.5 GenScript Recent Developments

5.8 Pfizer Inc.

5.8.1 Pfizer Inc. Profile

5.8.2 Pfizer Inc. Main Business

5.8.3 Pfizer Inc. Recombinant DNA Technology Products, Services and Solutions

5.8.4 Pfizer Inc. Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)

5.8.5 Pfizer Inc. Recent Developments

5.9 Novo Nordisk

5.9.1 Novo Nordisk Profile

5.9.2 Novo Nordisk Main Business

5.9.3 Novo Nordisk Recombinant DNA Technology Products, Services and Solutions

5.9.4 Novo Nordisk Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)

5.9.5 Novo Nordisk Recent Developments

5.10 Sanofi

5.10.1 Sanofi Profile

5.10.2 Sanofi Main Business

5.10.3 Sanofi Recombinant DNA Technology Products, Services and Solutions

5.10.4 Sanofi Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)

5.10.5 Sanofi Recent Developments

5.11 Merck KGaA

5.11.1 Merck KGaA Profile

5.11.2 Merck KGaA Main Business

5.11.3 Merck KGaA Recombinant DNA Technology Products, Services and Solutions

5.11.4 Merck KGaA Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)

5.11.5 Merck KGaA Recent Developments

5.12 Profacgen

5.12.1 Profacgen Profile

5.12.2 Profacgen Main Business

5.12.3 Profacgen Recombinant DNA Technology Products, Services and Solutions

5.12.4 Profacgen Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)

5.12.5 Profacgen Recent Developments

5.13 Biocon

5.13.1 Biocon Profile

5.13.2 Biocon Main Business

5.13.3 Biocon Recombinant DNA Technology Products, Services and Solutions

5.13.4 Biocon Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)

5.13.5 Biocon Recent Developments

5.14 GlaxoSmithKline

5.14.1 GlaxoSmithKline Profile

5.14.2 GlaxoSmithKline Main Business

5.14.3 GlaxoSmithKline Recombinant DNA Technology Products, Services and Solutions

5.14.4 GlaxoSmithKline Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)

5.14.5 GlaxoSmithKline Recent Developments

5.15 Cibus

5.15.1 Cibus Profile

5.15.2 Cibus Main Business

5.15.3 Cibus Recombinant DNA Technology Products, Services and Solutions

5.15.4 Cibus Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)

5.15.5 Cibus Recent Developments

5.16 Horizon Discovery Group

5.16.1 Horizon Discovery Group Profile

5.16.2 Horizon Discovery Group Main Business

5.16.3 Horizon Discovery Group Recombinant DNA Technology Products, Services and Solutions

5.16.4 Horizon Discovery Group Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)

5.16.5 Horizon Discovery Group Recent Developments

5.17 New England Biolabs

5.17.1 New England Biolabs Profile

5.17.2 New England Biolabs Main Business

5.17.3 New England Biolabs Recombinant DNA Technology Products, Services and Solutions

5.17.4 New England Biolabs Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)

5.17.5 New England Biolabs Recent Developments

6 North America

6.1 North America Recombinant DNA Technology Market Size by Country (2018-2029)

6.2 U.S.

6.3 Canada

7 Europe

7.1 Europe Recombinant DNA Technology Market Size by Country (2018-2029)

7.2 Germany

7.3 France

7.4 U.K.

7.5 Italy

7.6 Russia

7.7 Nordic Countries

7.8 Rest of Europe

8 Asia-Pacific

8.1 Asia-Pacific Recombinant DNA Technology Market Size by Region (2018-2029)

8.2 China

8.3 Japan

8.4 South Korea

8.5 Southeast Asia

8.6 India

8.7 Australia

8.8 Rest of Asia-Pacific

9 Latin America

9.1 Latin America Recombinant DNA Technology Market Size by Country (2018-2029)

9.2 Mexico

9.3 Brazil

9.4 Rest of Latin America

10 Middle East & Africa

10.1 Middle East & Africa Recombinant DNA Technology Market Size by Country (2018-2029)

10.2 Turkey

10.3 Saudi Arabia

10.4 UAE

10.5 Rest of Middle East & Africa

11 Recombinant DNA Technology Market Dynamics

11.1 Recombinant DNA Technology Industry Trends

11.2 Recombinant DNA Technology Market Drivers

11.3 Recombinant DNA Technology Market Challenges

11.4 Recombinant DNA Technology Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

13.4 Author List

FEATURED COMPANIES

Eli Lilly and Company

Horizon Discovery Group

New England Biolabs

List of Tables

Table 1. Global Market Recombinant DNA Technology Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029

Table 2. Global Recombinant DNA Technology Market Size by Region (2018-2023) & (US$ Million)

Table 3. Global Recombinant DNA Technology Market Size Share by Region (2018-2023)

Table 4. Global Recombinant DNA Technology Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 5. Global Recombinant DNA Technology Forecasted Market Size Share by Region (2024-2029)

Table 6. Global Recombinant DNA Technology Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029

Table 7. Global Recombinant DNA Technology Market Size by Type (2018-2023) & (US$ Million)

Table 8. Global Recombinant DNA Technology Revenue Market Share by Type (2018-2023)

Table 9. Global Recombinant DNA Technology Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 10. Global Recombinant DNA Technology Revenue Market Share by Type (2024-2029)

Table 11. North America Recombinant DNA Technology Revenue by Type (2018-2023) & (US$ Million)

Table 12. North America Recombinant DNA Technology Revenue by Type (2024-2029) & (US$ Million)

Table 13. Europe Recombinant DNA Technology Revenue by Type (2018-2023) & (US$ Million)

Table 14. Europe Recombinant DNA Technology Revenue by Type (2024-2029) & (US$ Million)

Table 15. Asia-Pacific Recombinant DNA Technology Revenue by Type (2018-2023) & (US$ Million)

Table 16. Asia-Pacific Recombinant DNA Technology Revenue by Type (2024-2029) & (US$ Million)

Table 17. Latin America Recombinant DNA Technology Revenue by Type (2018-2023) & (US$ Million)

Table 18. Latin America Recombinant DNA Technology Revenue by Type (2024-2029) & (US$ Million)

Table 19. Middle East and Africa Recombinant DNA Technology Revenue by Type (2018-2023) & (US$ Million)

Table 20. Middle East and Africa Recombinant DNA Technology Revenue by Type (2024-2029) & (US$ Million)

Table 21. Global Recombinant DNA Technology Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029

Table 22. Global Recombinant DNA Technology Market Size by Application (2018-2023) & (US$ Million)

Table 23. Global Recombinant DNA Technology Revenue Market Share by Application (2018-2023)

Table 24. Global Recombinant DNA Technology Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 25. Global Recombinant DNA Technology Revenue Market Share by Application (2024-2029)

Table 26. North America Recombinant DNA Technology Revenue by Application (2018-2023) & (US$ Million)

Table 27. North America Recombinant DNA Technology Revenue by Application (2024-2029) & (US$ Million)

Table 28. Europe Recombinant DNA Technology Revenue by Application (2018-2023) & (US$ Million)

Table 29. Europe Recombinant DNA Technology Revenue by Application (2024-2029) & (US$ Million)

Table 30. Asia-Pacific Recombinant DNA Technology Revenue by Application (2018-2023) & (US$ Million)

Table 31. Asia-Pacific Recombinant DNA Technology Revenue by Application (2024-2029) & (US$ Million)

Table 32. Latin America Recombinant DNA Technology Revenue by Application (2018-2023) & (US$ Million)

Table 33. Latin America Recombinant DNA Technology Revenue by Application (2024-2029) & (US$ Million)

Table 34. Middle East and Africa Recombinant DNA Technology Revenue by Application (2018-2023) & (US$ Million)

Table 35. Middle East and Africa Recombinant DNA Technology Revenue by Application (2024-2029) & (US$ Million)

Table 36. Global Recombinant DNA Technology Revenue (US$ Million) by Players (2018-2023)

Table 37. Global Recombinant DNA Technology Revenue Market Share by Players (2018-2023)

Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Recombinant DNA Technology as of 2022)

Table 39. Date of Key Players Enter into Recombinant DNA Technology Market

Table 40. Global Recombinant DNA Technology Key Players Headquarters and Area Served

Table 41. Recombinant DNA Technology Product Solution and Service

Table 42. Global Recombinant DNA Technology Players Market Concentration Ratio (CR5 and HHI)

Table 43. Mergers & Acquisitions, Expansion Plans

Table 44. Monsanto Company Basic Information List

Table 45. Monsanto Company Description and Business Overview

Table 46. Monsanto Company Recombinant DNA Technology Products, Services and Solutions

Table 47. Revenue (US$ Million) in Recombinant DNA Technology Business of Monsanto Company (2018-2023)

Table 48. Monsanto Company Recent Developments

Table 49. Roche Basic Information List

Table 50. Roche Description and Business Overview

Table 51. Roche Recombinant DNA Technology Products, Services and Solutions

Table 52. Revenue (US$ Million) in Recombinant DNA Technology Business of Roche (2018-2023)

Table 53. Roche Recent Developments

Table 54. Biogen Basic Information List

Table 55. Biogen Description and Business Overview

Table 56. Biogen Recombinant DNA Technology Products, Services and Solutions

Table 57. Revenue (US$ Million) in Recombinant DNA Technology Business of Biogen (2018-2023)

Table 58. Biogen Recent Developments

Table 59. Amgen Basic Information List

Table 60. Amgen Description and Business Overview

Table 61. Amgen Recombinant DNA Technology Products, Services and Solutions

Table 62. Revenue (US$ Million) in Recombinant DNA Technology Business of Amgen (2018-2023)

Table 63. Amgen Recent Developments

Table 64. Novartis Basic Information List

Table 65. Novartis Description and Business Overview

Table 66. Novartis Recombinant DNA Technology Products, Services and Solutions

Table 67. Revenue (US$ Million) in Recombinant DNA Technology Business of Novartis (2018-2023)

Table 68. Novartis Recent Developments

Table 69. Eli Lilly and Company Basic Information List

Table 70. Eli Lilly and Company Description and Business Overview

Table 71. Eli Lilly and Company Recombinant DNA Technology Products, Services and Solutions

Table 72. Revenue (US$ Million) in Recombinant DNA Technology Business of Eli Lilly and Company (2018-2023)

Table 73. Eli Lilly and Company Recent Developments

Table 74. GenScript Basic Information List

Table 75. GenScript Description and Business Overview

Table 76. GenScript Recombinant DNA Technology Products, Services and Solutions

Table 77. Revenue (US$ Million) in Recombinant DNA Technology Business of GenScript (2018-2023)

Table 78. GenScript Recent Developments

Table 79. Pfizer Inc. Basic Information List

Table 80. Pfizer Inc. Description and Business Overview

Table 81. Pfizer Inc. Recombinant DNA Technology Products, Services and Solutions

Table 82. Revenue (US$ Million) in Recombinant DNA Technology Business of Pfizer Inc. (2018-2023)

Table 83. Pfizer Inc. Recent Developments

Table 84. Novo Nordisk Basic Information List

Table 85. Novo Nordisk Description and Business Overview

Table 86. Novo Nordisk Recombinant DNA Technology Products, Services and Solutions

Table 87. Revenue (US$ Million) in Recombinant DNA Technology Business of Novo Nordisk (2018-2023)

Table 88. Novo Nordisk Recent Developments

Table 89. Sanofi Basic Information List

Table 90. Sanofi Description and Business Overview

Table 91. Sanofi Recombinant DNA Technology Products, Services and Solutions

Table 92. Revenue (US$ Million) in Recombinant DNA Technology Business of Sanofi (2018-2023)

Table 93. Sanofi Recent Developments

Table 94. Merck KGaA Basic Information List

Table 95. Merck KGaA Description and Business Overview

Table 96. Merck KGaA Recombinant DNA Technology Products, Services and Solutions

Table 97. Revenue (US$ Million) in Recombinant DNA Technology Business of Merck KGaA (2018-2023)

Table 98. Merck KGaA Recent Developments

Table 99. Profacgen Basic Information List

Table 100. Profacgen Description and Business Overview

Table 101. Profacgen Recombinant DNA Technology Products, Services and Solutions

Table 102. Revenue (US$ Million) in Recombinant DNA Technology Business of Profacgen (2018-2023)

Table 103. Profacgen Recent Developments

Table 104. Biocon Basic Information List

Table 105. Biocon Description and Business Overview

Table 106. Biocon Recombinant DNA Technology Products, Services and Solutions

Table 107. Revenue (US$ Million) in Recombinant DNA Technology Business of Biocon (2018-2023)

Table 108. Biocon Recent Developments

Table 109. GlaxoSmithKline Basic Information List

Table 110. GlaxoSmithKline Description and Business Overview

Table 111. GlaxoSmithKline Recombinant DNA Technology Products, Services and Solutions

Table 112. Revenue (US$ Million) in Recombinant DNA Technology Business of GlaxoSmithKline (2018-2023)

Table 113. GlaxoSmithKline Recent Developments

Table 114. Cibus Basic Information List

Table 115. Cibus Description and Business Overview

Table 116. Cibus Recombinant DNA Technology Products, Services and Solutions

Table 117. Revenue (US$ Million) in Recombinant DNA Technology Business of Cibus (2018-2023)

Table 118. Cibus Recent Developments

Table 119. Horizon Discovery Group Basic Information List

Table 120. Horizon Discovery Group Description and Business Overview

Table 121. Horizon Discovery Group Recombinant DNA Technology Products, Services and Solutions

Table 122. Revenue (US$ Million) in Recombinant DNA Technology Business of Horizon Discovery Group (2018-2023)

Table 123. Horizon Discovery Group Recent Developments

Table 124. New England Biolabs Basic Information List

Table 125. New England Biolabs Description and Business Overview

Table 126. New England Biolabs Recombinant DNA Technology Products, Services and Solutions

Table 127. Revenue (US$ Million) in Recombinant DNA Technology Business of New England Biolabs (2018-2023)

Table 128. New England Biolabs Recent Developments

Table 129. North America Recombinant DNA Technology Market Size by Country (2018-2023) & (US$ Million)

Table 130. North America Recombinant DNA Technology Market Size by Country (2024-2029) & (US$ Million)

Table 131. Europe Recombinant DNA Technology Market Size by Country (2018-2023) & (US$ Million)

Table 132. Europe Recombinant DNA Technology Market Size by Country (2024-2029) & (US$ Million)

Table 133. Asia-Pacific Recombinant DNA Technology Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 134. Asia-Pacific Recombinant DNA Technology Market Size by Region (2018-2023) & (US$ Million)

Table 135. Asia-Pacific Recombinant DNA Technology Market Size by Region (2024-2029) & (US$ Million)

Table 136. Asia-Pacific Recombinant DNA Technology Market Share by Region (2018-2023)

Table 137. Asia-Pacific Recombinant DNA Technology Market Share by Region (2024-2029)

Table 138. Latin America Recombinant DNA Technology Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 139. Latin America Recombinant DNA Technology Market Size by Country (2018-2023) & (US$ Million)

Table 140. Latin America Recombinant DNA Technology Market Size by Country (2024-2029) & (US$ Million)

Table 141. Middle East & Africa Recombinant DNA Technology Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 142. Middle East & Africa Recombinant DNA Technology Market Size by Country (2018-2023) & (US$ Million)

Table 143. Middle East & Africa Recombinant DNA Technology Market Size by Country (2024-2029) & (US$ Million)

Table 144. Recombinant DNA Technology Market Trends

Table 145. Recombinant DNA Technology Market Drivers

Table 146. Recombinant DNA Technology Market Challenges

Table 147. Recombinant DNA Technology Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Recombinant DNA Technology Market Size Year-over-Year 2018-2029 & (US$ Million)

Figure 2. Global Recombinant DNA Technology Market Size (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Recombinant DNA Technology Market Share by Regions: 2022 VS 2029

Figure 4. Global Recombinant DNA Technology Forecasted Market Size Share by Region (2024-2029)

Figure 5. North America Recombinant DNA Technology Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 6. Europe Recombinant DNA Technology Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 7. Asia-Pacific Recombinant DNA Technology Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 8. Latin America Recombinant DNA Technology Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 9. Middle East & Africa Recombinant DNA Technology Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 10. Product Picture of Therapeutic Agent

Figure 11. Global Therapeutic Agent Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 12. Product Picture of Vaccine

Figure 13. Global Vaccine Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 14. Product Picture of Biotech Crops

Figure 15. Global Biotech Crops Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 16. Product Picture of Specialty Chemicals

Figure 17. Global Specialty Chemicals Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 18. Global Recombinant DNA Technology Market Size Share by Type: 2022 & 2029

Figure 19. North America Recombinant DNA Technology Revenue Market Share by Type (2018-2029)

Figure 20. Europe Recombinant DNA Technology Revenue Market Share by Type (2018-2029)

Figure 21. Asia-Pacific Recombinant DNA Technology Revenue Market Share by Type (2018-2029)

Figure 22. Latin America Recombinant DNA Technology Revenue Market Share by Type (2018-2029)

Figure 23. Middle East and Africa Recombinant DNA Technology Revenue Market Share by Type (2018-2029)

Figure 24. Biotechnology and Pharmaceutical Companies Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 25. Academic & Government Research Institutes Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 26. Others Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 27. Global Recombinant DNA Technology Market Size Share by Application: 2022 & 2029

Figure 28. North America Recombinant DNA Technology Revenue Market Share by Application (2018-2029)

Figure 29. Europe Recombinant DNA Technology Revenue Market Share by Application (2018-2029)

Figure 30. Asia-Pacific Recombinant DNA Technology Revenue Market Share by Application (2018-2029)

Figure 31. Latin America Recombinant DNA Technology Revenue Market Share by Application (2018-2029)

Figure 32. Middle East and Africa Recombinant DNA Technology Revenue Market Share by Application (2018-2029)

Figure 33. Recombinant DNA Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

Figure 34. Global Top 5 and Top 10 Players Recombinant DNA Technology Market Share in 2022

Figure 35. North America Recombinant DNA Technology Market Share by Country (2018-2029)

Figure 36. U.S. Recombinant DNA Technology Market Size (2018-2029) & (US$ Million)

Figure 37. Canada Recombinant DNA Technology Market Size (2018-2029) & (US$ Million)

Figure 38. Germany Recombinant DNA Technology Market Size (2018-2029) & (US$ Million)

Figure 39. France Recombinant DNA Technology Market Size (2018-2029) & (US$ Million)

Figure 40. U.K. Recombinant DNA Technology Market Size (2018-2029) & (US$ Million)

Figure 41. Italy Recombinant DNA Technology Market Size (2018-2029) & (US$ Million)

Figure 42. Russia Recombinant DNA Technology Market Size (2018-2029) & (US$ Million)

Figure 43. Nordic Countries Recombinant DNA Technology Market Size (2018-2029) & (US$ Million)

Figure 44. Asia-Pacific Recombinant DNA Technology Market Share by Region (2018-2029)

Figure 45. China Recombinant DNA Technology Market Size (2018-2029) & (US$ Million)

Figure 46. Japan Recombinant DNA Technology Market Size (2018-2029) & (US$ Million)

Figure 47. South Korea Recombinant DNA Technology Market Size (2018-2029) & (US$ Million)

Figure 48. Southeast Asia Recombinant DNA Technology Market Size (2018-2029) & (US$ Million)

Figure 49. India Recombinant DNA Technology Market Size (2018-2029) & (US$ Million)

Figure 50. Australia Recombinant DNA Technology Market Size (2018-2029) & (US$ Million)

Figure 51. Latin America Recombinant DNA Technology Market Share by Country (2018-2029)

Figure 52. Mexico Recombinant DNA Technology Market Size (2018-2029) & (US$ Million)

Figure 53. Brazil Recombinant DNA Technology Market Size (2018-2029) & (US$ Million)

Figure 54. Middle East & Africa Recombinant DNA Technology Market Share by Country (2018-2029)

Figure 55. Turkey Recombinant DNA Technology Market Size (2018-2029) & (US$ Million)

Figure 56. Saudi Arabia Recombinant DNA Technology Market Size (2018-2029) & (US$ Million)

Figure 57. UAE Recombinant DNA Technology Market Size (2018-2029) & (US$ Million)

Figure 58. Bottom-up and Top-down Approaches for This Report

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions